LEADER 03315nam  22005173u 450 
001 9910504284403321
005 20250628110045.0
010   $a3-030-83114-0
035   $a(CKB)5340000000068494
035   $aEBL6794041
035   $a(AU-PeEL)EBL6794041
035   $a(MiAaPQ)EBC6794041
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/72805
035   $a(PPN)258302917
035   $a(ODN)ODN0010187420
035   $a(oapen)doab72805
035   $a(EXLCZ)995340000000068494
100   $a20220617d2021||||  u||         |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAccess to Medicines and Vaccines $eImplementing Flexibilities under Intellectual Property Law
210   $aCham $cSpringer International Publishing AG$d2021
215   $a1 online resource (x, 369 pages) $ccolor illustrations
300   $aDescription based upon print version of record.
311 08$a3-030-83113-2 
320   $aIncludes bibliographical references.
327   $tInterpreting the Flexibilities Under the TRIPS Agreement /$rCarlos M. Correa --$tIntellectual Property Exhaustion and Parallel Imports of Pharmaceuticals : a Comparative and Critical Review /$rIrene Calboli --$tCompulsory Licenses and Government Use : Challenges and Opportunities /$rYousuf A. Vawda --$tAccess to CRISPR Genome Editing Technologies : Patents, Human Rights and the Public Interest /$rDuncan Matthews --$tBolar Exception /$rViviana Munoz Tellez --$tPatent Oppositions in India /$rSandeep Kanak Rathod --$tProtection of Clinical Test Data and Public Health : A Proposal to End the Stronghold of Data Exclusivity /$rEllen 't Hoen --$tCourts and Pharmaceutical Patents : From Formalist Positivism to the Emergence of a Global Law /$rCalixto Salomao Filho, Vitor Henrique Pinto Ido --$tRobust Patent Examination or Deep Harmonization? Cooperation and Work Sharing Between Patent Offices /$rNirmalya Syam --$tIntellectual Property Rights (IPRs), Competition Law and Excessive Pricing of Medicines /$rMor Bakhoum --$tThe Impact of 'TRIPS-Plus' Rules on the Use of TRIPS Flexibilities : Dealing with the Implementation Challenges /$rMohammed El Said --$tPatent Linkages and Its Impact on Access to Medicines : Challenges, Opportunities for Developing Countries /$rK.D. Raju.
330   $a"This book is an outcome of a partnership between the Max Planck Institute (MPI) for Innovation and Competition and the South Centre, which jointly organized a Global Forum on Intellectual Property, Access to Medicine and Innovation in Munich on 9-10 December 2019"--Page v
606   $aPatent medicines$vCongresses
606   $aPatent medicines$xLaw and legislation$vCongresses
615  0$aPatent medicines
615  0$aPatent medicines$xLaw and legislation
686   $aBUS069000$aLAW000000$aLAW051000$aMED000000$2bisacsh
700   $aCorrea$b Carlos M$0464694
701   $aHilty$b Reto M$0233728
712 12$aGlobal Forum on Innovation, Intellectual Property and Access to Medicines$f(2019 :$eMunich, Germany)
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910504284403321
996   $aAccess to Medicines and Vaccines$92876125
997   $aUNINA